Generics in India

Generics in India

Code: ML-OHME4800 | Published: Jan-2016 | Pages: 37 | MarketLine
Price :
$350.00
USD

* Required Fields

$350.00

Details

Generics in India industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the India generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

- For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the generic-eligible market, are not included.

- The Indian generics market is expected to generate total revenues of $13.1bn in 2015, representing a compound annual growth rate (CAGR) of 14% between 2011 and 2015.

- Market consumption volume is forecast to reach a total of 95.1 % of total pharma volume in 2015.

- The Indian generics market is one of the largest in the world and the market is set to grow due to an ageing population, increased consumer spending, raising healthcare insurance, and rapid urbanization.

Key Findings
Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in India

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in India

Leading company profiles reveal details of key generics market players global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the India generics market with five year forecasts by both value and volume

Macroeconomic indicators provide insight into general trends within the India economy

Reasons To Buy
What was the size of the India generics market by value in 2015?

What will be the size of the India generics market in 2020?

What factors are affecting the strength of competition in the India generics market?

How has the market performed over the last five years?

How large is Indias generics market in relation to its regional counterparts?

Table of Contents

TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Market volume 2
Market volume forecast 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market volume 9
Market Segmentation 10
Geography segmentation 10
Market Outlook 11
Market value forecast 11
Market volume forecast 12
Five Forces Analysis 13
Summary 13
Buyer power 14
Supplier power 15
New entrants 16
Threat of substitutes 17
Degree of rivalry 18
Leading Companies 19
Aurobindo Pharma Limited 19
Cipla Limited 22
Lupin Limited 25
Sun Pharmaceutical Industries Ltd. 29
Macroeconomic Indicators 32
Country Data 32
Methodology 34
Industry associations 35
Related MarketLine research 35
Appendix 36
About MarketLine 36

List of Tables
Table 1: India generics market value: $ billion, 2011-15(e)
Table 2: India generics market volume: % of total pharma volume, 2011-15(e)
Table 3: India generics market geography segmentation: $ billion, 2015(e)
Table 4: India generics market value forecast: $ billion, 2015-20
Table 5: India generics market volume forecast: % of total pharma volume, 2015-20
Table 6: Aurobindo Pharma Limited: key facts
Table 7: Aurobindo Pharma Limited: key financials ($)
Table 8: Aurobindo Pharma Limited: key financials (Rs.)
Table 9: Aurobindo Pharma Limited: key financial ratios
Table 10: Cipla Limited: key facts
Table 11: Cipla Limited: key financials ($)
Table 12: Cipla Limited: key financials (Rs.)
Table 13: Cipla Limited: key financial ratios
Table 14: Lupin Limited: key facts
Table 15: Lupin Limited: key financials ($)
Table 16: Lupin Limited: key financials (Rs.)
Table 17: Lupin Limited: key financial ratios
Table 18: Sun Pharmaceutical Industries Ltd.: key facts
Table 19: Sun Pharmaceutical Industries Ltd.: key financials ($)
Table 20: Sun Pharmaceutical Industries Ltd.: key financials (Rs.)
Table 21: Sun Pharmaceutical Industries Ltd.: key financial ratios
Table 22: India size of population (million), 2011-15
Table 23: India gdp (constant 2005 prices, $ billion), 2011-15
Table 24: India gdp (current prices, $ billion), 2011-15
Table 25: India inflation, 2011-15
Table 26: India consumer price index (absolute), 2011-15
Table 27: India exchange rate, 2011-15

List of Figures
Figure 1: India generics market value: $ billion, 2011-15(e)
Figure 2: India generics market volume: % of total pharma volume, 2011-15(e)
Figure 3: India generics market geography segmentation: % share, by value, 2015(e)
Figure 4: India generics market value forecast: $ billion, 2015-20
Figure 5: India generics market volume forecast: % of total pharma volume, 2015-20
Figure 6: Forces driving competition in the generics market in India, 2015
Figure 7: Drivers of buyer power in the generics market in India, 2015
Figure 8: Drivers of supplier power in the generics market in India, 2015
Figure 9: Factors influencing the likelihood of new entrants in the generics market in India, 2015
Figure 10: Factors influencing the threat of substitutes in the generics market in India, 2015
Figure 11: Drivers of degree of rivalry in the generics market in India, 2015
Figure 12: Aurobindo Pharma Limited: revenues and profitability
Figure 13: Aurobindo Pharma Limited: assets and liabilities
Figure 14: Cipla Limited: revenues and profitability
Figure 15: Cipla Limited: assets and liabilities
Figure 16: Lupin Limited: revenues and profitability
Figure 17: Lupin Limited: assets and liabilities
Figure 18: Sun Pharmaceutical Industries Ltd.: revenues and profitability
Figure 19: Sun Pharmaceutical Industries Ltd.: assets and liabilities
Aurobindo Pharma Limited, Cipla Limited, Lupin Limited, Sun Pharmaceutical Industries Ltd.

Report Format

Following are different modes of Licenses.

a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.

b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.

c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.

Quick Help

1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :

a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]

b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]


2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:

a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
d. Paypal


3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.

If you have a more question about our publications please see our FAQs section or contact us now at cs@marketinforesearch.com.

CUSTOMERS WHO VIEWED THIS REPORT ALSO VIEWED

There are no reports matching the selection.

Browse similar reports by category:
Pharmaceuticals & Healthcare
MarketLine

Our Clients